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Abstract
Four monoclonal antibodies (mAb) to bovine serum albumin (BSA) were purified from
mouse ascites fluid by the method of affinity chromatography. Two different affinity
devices with approximately the same binding capacity for antibody were used: a col-
umn containing Sepharose CL-4B resin and an Acti-Disk GTA membrane cartridge,
both of which having BSA covalently coupled to the matrix. Significant quantities
(> 0.5 mg) of clones 3C2, 3C9, 1N3 and 1N16 were successfully obtained using these
two devices; attempts to obtain a fifth mAb (clone 2-11) in purified form were un-
successful. Native polyacrylamide gel electrophoresis showed that the highest purity
was obtained when using the Sepharose column. Use of the Acti-Disk cartridge re-
quired an extra washing step in order to yield mAb of sufficient purity for use in later
experiments.
Association constants (Ka) for each of the four mAb purified were determined by
radioimmunoassay. The constants (in M- 1) obtained by Scatchard analysis of the
data were as follows: 3C2, 5.6x10 7; 3C9, 1.3x107; 1N3, 1.2x108; 1N16, 4.1x10 7. The
Scatchard data for clones 3C2 and 1N16 displayed linear behavior, whereas the data
for clones 3C9 and 1N3 were highly nonlinear. Values of Ka determined for 3C2
and 1N16 therefore represent intrinsic association constants, whereas those for 3C9
and 1N3 represent average affinities. Quasi-elastic light scattering (QLS) was used to
investigate the sizes of complexes formed from BSA and pairs of anti-BSA mAb. With
one pair (3C2 + 1N16), QLS showed an increase in the average hydrodynamic radius
of the system as the concentrations of BSA and mAb increased. Size distributions
of complexes formed from this pair and two other pairs (3C2 + 1N3 and 3C9 +
1N16) at a single concentration were also obtained by CONTIN analysis of QLS data.
Diameters ranging from 6 to 50 nm were observed in each distribution, indicating the
presence of complexes containing between one and five mAb.
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Chapter 1
Introduction and Thesis
Objectives
1.1 Antibodies and Humoral Immunity
The invasion by a foreign substance into humans and many other animals often results
in a response to eliminate and clear the invasive substance by the host. One such
response is the production of proteins known as antibodies (Ab'). Ab are protein
molecules which bind non-covalently and specifically to the substance that caused
their production (called the antigen (Ag), usually another protein or polysaccharide
of viral or bacterial origin). The most prevalent type of Ab is the immunoglobulin G
molecule (IgG), the general structure of which is shown in Figure 1-1.
A single IgG molecule is composed of four polypeptide chains: two identical heavy
chains (M.W. - 50 kDa each) and two identical light chains (M.W. - 25 kDa each)
which are linked through disulfide bridges to form the Y-shaped structure shown
[38]. The two arms of IgG are referred to as the Fab regions and contain the amino
acid residues responsible for Ag recognition and binding. Thus, each IgG molecule
contains two identical sites which can form an association with Ag. The stem region
1Throughout this thesis, the following abbreviations will be used: Ab, antibody; mAb, mono-
clonal antibody; Ag, antigen; IgG, immunoglobulin G; IC, immune complexes; and BSA, bovine
serum albumin.
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Figure 1-1: Structure of Immunoglobulin G (IgG).
of IgG is known as the Fc region and is directly involved in a number of effector
functions common to many immunoglobulins, including Fc-mediated phagocytosis,
antibody-dependent cell-mediated cytotoxicity, and complement activation [6].
While an Ab may have binding specificity for a particular Ag (a protein, for
example), the physical association occurs only within a specific region on the Ag
molecule. This physical region is known as an epitope of the Ag. Because an Ag
can in principle have many epitopes within its molecular structure, a single Ag can
elicit the production of many different Ab, each one having specificity for a different
epitope on the same Ag. This set of all Ab produced in response to a particular Ag
is known as polyclonal Ab against the Ag. Due to the multivalent nature of both
polyclonal Ab and Ag, aggregates known as immune complexes (IC) can be formed
when the two are combined, as shown conceptually in Figure 1-2.
When formed in the bloodstream, IC are normally cleared by the reticuloendothe-
lial system. If these complexes are small enough and can elude clearance by such
mechanisms, they can either remain in the circulation in soluble form, or can be de-
posited in certain tissues resulting in tissue damage and injury. In addition, they may
play an immunoregulatory role in a number of diseases. Elevated levels of IC have
been identified in connection with the autoimmune disorders rheumatoid arthritits,
10
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systemic lupus erytlirnatoses, and juvanile diabetes [41, 14]; the infectious diseases vi-
ral hepatitis, bacterial endocardidtis, and leprosy [41, 14]; aquired immunodeficiency
syndrome (AIDS) [8]; and a variety of forms of cancer [1, 9]. A clearer understanding
of the role IC play in the pathology of each of these diseases depends on knowledge
of the physical chemistry of IC and of the variety of biological interactions they are
involved ill i vivo.
1.2 Monoclonal Antibodies
As mentioned above, the normal mammalian response to presentation of a single Ag
is the production of polyclonal Ab, containing Ab which differ both with respect to
epitope specificity and the strenth of the Ab-Ag association. This is due to the fact
that each individual contains an enormous number (possibly > 109 in humans) of
different clones of Ab-producing lymphocytes, each of which produces an Ab unique
in its precice amino acid sequence, and therefore in its Ag specificity and affinity.
A monoclonal Ab (mAb) is the product of a unique cell line known as a hybridoma
cell, the development of which was first reported by K6oler and Milstein in 1976 [21]. A
hivbridoma cell line is produced by the fusion of a mouse spleen cell (responsible for the
particular Ab which is produced) to a mouse myeloma cell (allowing for unlimited
cell growth and enhanced Ab secretion). Because each fused cell line obtained is
derived from a single precursor B lymphocyte, the Ab produced by a particular cell
line will be molecularly homogeneous. Therefore a mAb, unlike polyclonal Ab, can
be characterized by a unique amino acid sequence, and can generally be characterized
in terms of a specific epitope for Ag binding and a single association constant.
The development of monoclonal antibodies has led to a large number of appli-
cations invloving their use. Monoclonals call be dleveloped to a variety of protein
Ag, andl can be used in novel ways to probe the protein structure and function [32].
Another application involves mAb to certain cell surface proteins for use in imninuno-
cytochemistrv, allowing microscopic identification of cell types [40]. Mlonoclonals can
also aid in protein purification, where the impure protein is first used to raise mAb
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to it, and then the isolated mAb is used to obtain the protein in a more purified form
[16]. Development of mAb to tumor or other target Ag has also led to new diagnostic
techniques and to the testing of new immunotherapies for the treatment of cancer
and other diseases [11, 42].
Another interesting application involves the use of mAb to study the formation
and biochemistry of Ag-Ab complexes. Relatively simple IC can be formed by mixing
Ag with a small number of mAb to the Ag. These simple IC allow investigation
of various aspects of IC formation and interactions utilizing a system that can be
readily modeled. Previous work in this area has involved light scattering and electron
microscopic studies of very simple IC in order to develop such models [30, 29, 31]. Ul-
timately, the complexity of the system can be increased by including greater numbers
of mAb, thereby more closely mimicking the true in vivo situation of polyclonal Ab.
The cost of this increase in complexity is the accompanying difficulty in developing
models to describe the system. Recent efforts [17] have focused on this problem.
1.3 Bovine Serum Albumin
Bovine serum albumin (BSA) is a serum protein consisting of a single polypeptide
chain of 582 amino acids (M.W. 67 kDa), the overall structure and phylogeny of
which have been studied extensively [5]. The protein consists of nine loops and can be
divided into three independently-folding domains, each of which contains at least two
distinct, non-cross-reacting antigenic regions [2]. Thus, the BSA molecule presents a
minimum of six antigenic regions, each containing multiple epitopes, for the elicitation
of Ab. Competitive binding experiments involving a panel of 64 different mAbs have
identified at least 33 distinct epitopes within the BSA molecule [26].
A large number of mAb against BSA have been developed, the collection of which
represents the composition of polyclonal antisera with reasonable accuracy [26]. A
system consisting of BSA and mAb to BSA is therefore an attractive one for use in
studying model IC.
13
1.4 Thesis Objectives
The objectives of this thesis were to:
1. Purify several monoclonal antibodies to bovine serum albumin using the tech-
nique of affinity chromatography.
2. Determine the equilibrium association constant for each antibody with respect
to its interaction with BSA.
3. Characterize small complexes formed between pairs of antibody and BSA in
solution with respect to their hydrodynamic size.
This work was motivated by the need for simple, well-characterized IC for use in
protein A and complement component binding studies. Previous work had been per-
formed in our laboratory using a set of anti-BSA mAb belonging to a non-complement-
binding subclass of mouse IgG. The mAb used in this thesis belonged to mouse sub-
classes shown to bind and activate human complement.
14
Chapter 2
Affinity Purification of
Monoclonal Antibodies
2.1 Introduction
In practice, mAb are generally produced by the injection of hybridoma cells into the
peritoneal cavity of a mouse. Over a period of time the cells will produce the mAb
and secrete their product into the ascites fluid. The fluid is then tapped several
days post-injection in order to harvest the mAb. Depending on the end use, the
mAb may require further purification, with different applications requiring different
levels of purity. For our studies, which involved determining binding parameters and
investigating sizes of Ag-mAb complexes, it was necessary to have monomeric mAb
of relatively high purity.
Several techniques are commonly employed for the purification of mAb from as-
cites fluid. These include precipitation by ammonium sulfate [45], ion exchange chro-
matography [36], protein A chromatography [15], anti-Ig chromatography [18], and
Ag-affinity chromatography [7]. Each of these techniques has advantages and disad-
vantages; some are cheap but yield mAb of low purity or specificity, while others are
expensive and/or tedious but yield mAb of higher purity and specificity.
The method of affinity chromatography (see Figure 2-1) takes advantage of the
fact that the protein to be purified (called the ligate, in this case the mAb) has
15
BSA Subdomain Specificity
3C2
3C9
1N3
1N16
2-11
3-C
3-C
1-N
1-N
2
IgG2b
IgG2b
IgG2a
IgG2b
IgG3
Table 2.1: nMIonoclonal Antibodies to BSA.
binding specificity for some other availible protein or chemical compound (called the
ligand, in this case the protein Ag). The ligand is covalently attached to some inert
matrix material, and the mixture containing the ligate is contacted with this material,
resulting in preferential binding of ligate to ligand. After washing any non-specifically
associated species from the matrix, the ligate can then be eluted by disrupting the
ligate-ligand interaction, usually by lowering the pH of the system. The result is a
product of relatively high purity and specificity for the immobilized ligand. For the
mnAb used in our study, we chose this method of purification due to our requirement
for highly pure, highly specific mAb.
2.2 Materials and Methods
2.2.1 Materials
Monoclonal Antibodies
The mAb used in this study were the generous gift of Dr. David Benjamin (University
of Virginia School of Medicine, Charlottesville, VA). Five different monoclonals with
binding specificity for BSA were obtained in frozen mouse ascites fluid and were
stored at -70°C. Table 2.1 lists the five clones which were received. along with their
corresponding IgG subclass and the sub(lomain on the BSA molecule (e.g., 1-N being
the N-terminal region of domain 1) containing the site to which they bind.
16
Clone IgG Subclass
:I
I
Adsorption
Ligate
Wash
Elution
Figure 2-1: Principle of Affinity Chromatography
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Matrix
_-1
Affinity Supports
Two different physical support materials were used for affinity purification of mAb
from ascites: Sepharose CL-4B (Pharmacia Biotech, Piscataway, NJ) and Acti-Disk
GTA Cartridge (FMC BioProducts, Rockland, ME):
Sepharose CL-4B. Sepharose CL-4B is a matrix of beaded 4% agarose (wet bead
diameter ranging from 45-165 [tm) with the polysaccharide chains cross-linked by
reaction with 2,3-dibromopropanol. The matrix is obtained in non-activated form,
and must be activated chemically in order to attach the desired ligand.
Acti-Disk GTA Cartridge. The Acti-Disk GTA Cartridge consists of a microporous
polymeric membrane sheet (47 mm diameter x 0.55 mm thickness) sealed in a 3
ml polypropylene housing. Glutaraldehyde groups are covalently crosslinked to the
polymer matrix, resulting in a pre-chemically functionalized structure for customized
ligand attachment. Amine groups of the protein to be immobilized react with the
glutaraldehyde moities within the matrix according to Schiff base chemistry, and these
bonds can be stabilized by reduction with sodium borohydride.
Bovine Serum Albumin
BSA, fraction V powder, was obtained from the Sigma Chemical Co. (St. Louis, MO),
and was dissolved in buffers appropriate for coupling to each material. Concentrations
of BSA in solution were determined by measuring optical density at 280 nm using a
model DU-50 single-beam spectrophotometer (Beckman Instruments, Somerset, NJ)
and assuming an extinction coefficient for BSA of 0.66 ml/(mg-cm).
2.2.2 Methods
Ligand Immobilization
Immobilization of BSA to Sepharose. Sepharose CL-4B was activated using 1-cyano-
4-dimethylamino pyridinium tetrafluoroborate (CDAP) resulting in the formation of
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active cyanate ester groups (-O-C-N) on the carbohydrate resin [22]. Approximately
25 grams of resin was first drained (Sepharose CL-4B is packaged in 20% ethanol)
on a fritted glass funnel and then washed sequentially with 100 ml of each of the
following: water, ice-cold 30% acetone in water, and ice-cold 60% acetone in water.
The washed Sepharose was then resuspended in 25 ml ice-cold 60% acetone, and
the flask containing the suspension was placed in an ice bath mounted on an orbital
shaker. Under vigorous agitation, 0.625 ml of 0.1 g/ml CDAP (Sigma) in water was
then added, and the activation reaction was initiated by addition of 0.5 ml of 0.2 M
triethylamine in water, 50 yl at a time. The reaction was allowed to proceed for 2
minutes, after which time the suspension was transferred into 250 ml ice-cold washing
medium (acetone:0.1 N HCl = 1:1). Prior to the coupling step, the Sepharose resin
was washed on a fritted glass funnel with 1 liter of cold water, followed by 1 liter cold
coupling buffer (0.1 M sodium bicarbonate, pH 8.5).
Coupling of BSA to the activated resin was performed in a similar fashion as for
CNBr-activated materials [23]. Washed and activated Sepharose was first transferred
to a flask containing 25 ml of 10 mg/ml BSA dissolved in the bicarbonate coupling
buffer. The coupling reaction was allowed to proceed with agitation overnight at
4°C. Coupling was terminated by draining the resin on a fritted glass funnel followed
by washing with 1 liter phosphate-buffered saline containing sodium azide (PBSA:
0.15 M NaCl, 0.01 M KH 2PO 4/K 2HPO 4, 0.02% (w/v) NaN 3, pH 7.0). The washed
Sepharose was finally resuspended in PBSA and stored at 4°C. The resin with BSA
covalently coupled will be referred to as BSA-Sepharose or BSA-Sepharose CL-4B.
Immobilization of BSA to Acti-Disk. The Acti-Disk GTA Cartridge is pre-activated
with glutaraldehyde functional groups, and is therefore ready for coupling via Schiff
base. chemistry, as shown in Figure 2-2. Coupling was carried out according to the
manufacturer's instructions with slight modification. The cartridge was connected
to a peristaltic pumping system and flushed with deionized water at a flow rate of
6 ml/min for 10 minutes. This was followed by equilibration with Buffer A (0.5 M
NaCl, 0.01 M KH2PO 4/K 2HPO 4, pH 7.2) for 15 minutes at a flow rate of 6 ml/min.
19
H H
I Schiff I NaBH 4
Matrix-C=O + R-NH2 = Moicty-C=N-R + H - Matrix-C-N-R
base H
aldchyde
amide
Figure 2-2: GTA Coupling Chemistry.
Coupling was performed by recirculating 40 ml of BSA in Buffer A (4 mg/ml) through
the cartridge at 6 ml/min for one hour. This was followed by washing with Buffer A at
10 ml/min for 10 minutes. Blocking of residual unreacted glutaraldehyde groups was
carried out by first recirculating 30 ml of 1 MI Tris. pH 7.5 through the cartridge for 1
hour, followed by recirculating two separate volumes of 40 ml freshly prepared sodium
borohvdride in Buffer A (2 mg/ml sodium borohydride) for 1 hour each. Finally, the
cartridge was flushed again with Buffer A at 10 ml/min for 10 minutes, equilibrated
with PBSA. and stored at 4C. The cartridge with BSA covalentl attached will be
referred to as the BSA-Acti-Disk.
Monoclonal Antibody Purification
For purifications using BSA-Sepharose, approximately 5 ml of resin was poured into
a 1 cm ID glass column, and an Econo-column flow adapter (BioRad, Hercules, CA)
was positioned above the settled resin. No further preparation was necessary when
using the BSA-Acti-Disk cartridge. In either case, the device (column or cartridge)
was installed into the chromatography system schematized in Figure 2-3. The system
consisted of either a Cole-Parmer Mlasterflex (Niles, IL) or an ISCO Tris (Lincoln, NE)
peristaltic pump, the affinity device, an ISCO UA-5 UV detector, and a Pharmacia
Frac-100 fraction collector, all connected in series by Tygon tubing.
For each mAb purified using BSA-Sepharose, 600 /l of the corresponding thawed
ascites fluid was diluted into 2 ml PBSA and mixed well; for purifications using the
BSA-Acti-Disk, the corresponding volumes were 200 1l of ascites and 2 ml PBSA.
The resulting diluted ascites was filtered twice through Millex GV 0.22 pm syringe
20
artridge '
Figure 2-3: Affinitv Chromatography Schematic.
filters (lillipore, Bedford, MA) prior to loading. For purifications involving the BSA-
Sepharose column, a flow rate of 2.2 ml/min during loading was maintained; for those
involving the BSA-Acti-Disk, a higher flow rate of 5 ml/min was used. Loading was
performed either in single pass fashion, or by recirculating the diluted ascites through
the device for 30 minutes. Non-specifically bound proteins were then removed by
washing the column with PBSA until the UV absorbance at 280 nm reached the
baseline value.
Elution of mAb was accomplished by application of a low pH glycine buffer to the
column or cartridge. For runs performed using BSA-Sepharose, 0.1 MI glycine/HC1,
pH 2.5, was used to elute bound mAb; for those performed using the BSA-Acti-Disk
cartridge, 0.1 M glycine in 2%(v/v) acetic acid, pH 3.2, was used. Later runs involving
the Acti-Disk cartridge also included a "pre"-elution step, where a high salt buffer (1
M1 NaCI, 0.01 XM iKH2PO 4/K2HPO4, pH 7.0) was used to remove any non-specifically
adsorbed proteins from the cartridge. Protein-containing fractions collected during
the low pH elution were pooled and immediately placed into Spectra/Por 7 dialy-
sis tubing having a nominal molecular weight cutoff of 25 kDa (Spectrum, Houston,
21
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TX). The eluted protein was dialyzed extensively against PBSA at 4C, and con-
centrated using Centriprep-30 centrifugal concentrators (Amicon, Beverly, MA) in
an IEC MIodel PR-6 swinging bucket centrifuge. Concentrations were determined by
measuring the optical density at 280 nm and assuming an extinction coefficient of 1.4
ml/(mg-cm) for IgG.
Native Polyacrylamide Gel Electrophoresis (Native PAGE)
Gel electrophoresis of purified mAb was performed using a Pharmacia PhastSystem
electrophoresis unit. Proteins were separated under non-denaturing, non-reducing
conditions by means of gradient gels [10]. In gradient gels, the nominal pore size
within the gel decreases continuously throughout; thus, under the same electric field,
proteins can be separated on the basis of hydrodynamic size due to hindrance effects.
Samples of 1 l were applied to Pharmacia PhastGel Gradient 8-25 gels, and were
separated according to the standard program provided by Pharmacia. Two lanes of
Pharmacia Native PAGE High Molecular Weight Standards (containing 1 mg/ml of
each of the following: albumin, M.W. 67 kDa; lactate dehydrogenase, MI.W. 140 kDa;
catalase, MI.W. 232 kDa; ferritin, MI.W. 440 kDa; and thyroglobulin, M.W. 669 kDa)
were included on each gel to determine relative mobilities of sample proteins. Protein
bands were visualized by coomassie blue staining (PhastGel Blue R, Pharmacia).
2.3 Results and Discussion
The amount of BSA covalently coupled to the Sepharose resin was determined by
mass balance to be 3.5 mg/ml of gel, or 87.5 mg BSA total. Based on the quantities
of reagents used for activation, an estimated maximum coupling capacity of 5 mol
of ligalnd per ml resin has been reported using CDAP activation chemistry [22]. For
BSA (M.W. 67 kDa) this corresponds to a maximum coupling capacity of 334
mg/ml of gel. It would appear, then, that the coupling achieved in this study was
far less than the maximum possible. This maximum capacity, however, is based on
the approximate total number of active cyanate ester groups (-O-C-N) which are
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formed upon reaction of CDAP with the carbohydrate resin. Due to the porous na-
ture of Sepharose, we would expect that many of these ester groups may be situated
in regions which are inaccessible to the large BSA macromolecule. In addition, many
active groups are likely to be in close proximity to one another. In such a case, an
equimolar attachment of BSA molecules to these neighboring cyanate ester groups
would be sterically hindered. Therefore, the amount of BSA immobilized in this study
seems reasonable, and is well within the range of capacities quoted for a number of
commercially-prepared affinity resins.
The amount of BSA attached to the Acti-Disk membrane was determined by mass
balance to be 19.4 mg. This value is compared to an approximate maximum coupling
capacity of 25-30 mg according to FMC product literature. Thus, between 65 and 78%
of the maximum capacity was achieved. This failure to achieve maximum capacity
was most likely the result of improper flow distribution across the membrane surface
during the coupling procedure. During some steps, fluid channeling and occasional
bubbles were observed within the translucent plastic housing. It is likely that portions
of the membrane surface were not exposed to the BSA ligand, resulting in incomplete
utilization of the GTA groups.
A total of 39 purifications of mAb were performed on ascites samples of the five
clones listed in Table 2.1. Seven purifications were performed using the BSA-Acti-Disk
cartridge without the high salt wash step, 22 were performed using the cartridge with
the high salt wash step, and 10 were performed using the BSA-Sepharose column. The
addition of the high salt wash when using the Acti-Disk cartridge was prompted by
the low level of mAb purity obtained without such a step (see below and Figure 2-7).
UV absorbance data as obtained from the ISCO-UA5 detector for three of the
purifications are presented in Figures 2-4 through 2-6. Several features can be seen
in the figures. In each, the breakthrough of non-bound protein is marked by a large
initial absorbance peak occurring a few minutes following the introduction of ascites
onto the column or cartridge. This absorbance then decays in an oscillatory fashion
as the ascites is recycled through the particular device, indicating that more protein
is binding to the device. In the case of BSA-Sepharose, this oscillation in absorbance
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Figure 2-4: UV Absorbance Trace. UV absorbance at 280 nm vs. elution volume for
mAb 3C2 purified on BSA-Sepharose, with recycle.
does not appear to fall after the first or second oscillation, and appears significantly
more erratic than in the case of the BSA-Acti-Disk. In all three figures the absorbance
fails to return to the baseline value during this recycle period, indicating that unbound
protein remains in solution. The UV absorbance then quickly returns to baseline upon
introduction of the PBSA wash. Finally, a sharp peak is observed corresponding to
protein eluted by application of the low pH glycine buffer. In the case of Figure 2-
6, there are two elution peaks: the.first corresponding to weakly-associated protein
eluted during the high salt buffer wash, and the second corresponding to strongly-
associated protein (mAb) eluted by the glycine buffer.
The amount of protein obtained from each purification was determined, and the
average yield values for each mAb/method combination are listed in Table 2.2. The
numbers in parentheses correspond to the number of purifications of each mAb using
each particular method. In general, the yield of each mAb decreased in the order 3C2
> 1N16 > 3C9 > 1N3 > 2-11. The yield of mAb 2-11 was extremely low (negligible
when using the high salt wash/BSA-Acti-Disk); thus, no further efforts to purify this
mAb were made.
The maximum binding capacity of the two affinity devices can be estimated by
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Figure 2-5: UV Absorbance Trace. UV absorbance at 280 nm vs. elution volume for
mAb 3C2 purified on BSA-Acti-Disk cartridge, with recycle. High salt wash step was
not performed.
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Figure 2-6: UV Absorbance Trace. UV absorbance at 280 nm vs. elution volume
for mAb 3C2 purified on BSA-Acti-Disk cartridge, with recycle. High salt wash was
performed prior to elution of mAb.
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Average Yield (mg)
BSA-Acti-Disk,
No Wash
1.35 (2)
0.85 (1)
0.78 (2)
1.09 (1)
0.64 (1)
Average Yield (mg)
BSA-Acti-Disk,
High Salt WVash
0.96 (4)
0.66 (5)
0.55 (6)
0.76 (4)
0.01 (3)
Average Yield (mg)
BSA-Sepharose
3.30 (5)
- (0)
- (0)
1.50 (5)
- (0)
Table 2.2: Average Yield of Affinity-Purified mAb. mAb were purified from 0.2
ml ascites (BSA-Acti-Disk) or 0.6 ml ascites (BSA-Sepharose) as described in Sec-
tion 2.2.2. NVumber in parentheses indicates number of purifications performed with
that method.
assuIlling that every BSA molecule immobilized is immunoreactive for each mAb.
This assumes that each BSA molecule is immobilized such that every epitope is ex-
posed and displays is native conformation. In such a case, the estimated maximum
mAb-binding capacities would be 40.1 mg and 44.5 mg for a 5 ml column of BSA-
Sepharose and the BSA-Acti-Disk cartridge, respectively. The calculated yields listed
in Table 2.2 would suggest that the saturation capacity of these materials was not
reached under the conditions used in this study. It is interesting to note the effects
of increasing the ascites load by a factor of three using the BSA-Sepharose column
versus the BSA-Acti-Disk. The average yield of mAb 3C2 obtained at this higher
load increased by over a factor of three, whereas the average yield of 1N16 increased
by only a factor of two. Thus, it would appear that BSA-Sepharose was slightly
more efficient than the BSA-Acti-Disk for the purification of mAb 3C2 (5.5 versus 4.8
mg/ml ascites), whereas the reverse was true for the purification of mAb 1N16 (2.5
versus 3.8 mg/ml).
The eluted and dialyzed protein obtained by these three methods was analyzed
by native PAGE in order to determine the electrophoretic nature and homogeneity
of the product. Figure 2-7 shows three such native PAGE gels: one each for protein
eluted from the BSA-Acti-Disk both with and without the high salt wash step, and
one for protein eluted from BSA-Sepharose. In general, the intensities of the bands
corresponding to mAb are consistent with yield measurements: intensities decrease
in the order 3C2 > 1N16 > 3C9 > 1N3 > 2-11. Also evident is the difference in the
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Figure 2-7: Native PAGE Gels. A. Protein purified using BSA-Acti-Disk (without
high salt wash): lane 1, MW Standards; lanes 2 and 4, N3; lane 3, 1N16; lane 5,
3C9; lane 6, 2-11; lane 7, 3C2; lane 8, MW Standards. B. Protein purified using
BSA-Acti-Disk (with high salt wash): lane 3, MW Standards; lane 4, N16; lane 5,
3C,9; lane 6, 3C2; lane 7, 2-11; lane 8, MW Standards. C. Protein purified using
BSA-Sepharo.se: lane 1, MW Standards; lanes 2-5, empty; lane 6, N16; lanes 7,
3C2; lane 8, MW Standards. In all gels, MW increases from bottom to top.
apparent purity using each method: the purity increases in the order BSA-Acti-Disk
(no wash) < BSA-Acti-Disk (wash) < BSA-Sepharose.
As seen in Figure 2-7.A, the homogeneity of the protein obtained using the BSA-
Acti-Disk without the additional wash step was especially poor, with numerous pro-
tein bands of both higher and lower molecular weight visible. This may have been due
to a high degree of non-specific adsorption of other ascites proteins to the Acti-Disk
membrane. In addition, the likelyhood of there existing residual non-reduced glu-
taraldehyde groups may have contributed to this problem. As mentioned earlier, an
estimated 22 to 35% of the glutaraldehyde groups availible for BSA ligand attachment
were not utilized during the coupling procedure. The sodium borohydride reduction
step following coupling should have resulted in the inactivation of such unreacted glu-
taraldehyde moities; however, the completion of this reduction step was determined
visually, with the membrane color turning from reddish-brown to yellow to indicate
reduction. Although the entire membrane surface did exhibit this color change, the
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final yellow color was not entirely homogeneous, suggesting that small areas of the
membrane may not have been exposed to chemical reduction. Any glutaraldehyde
groups in such areas would have remained active and capable of binding other ascites
proteins.
Because of the poor purity obtained using the BSA-Acti-Disk initially, the high
salt wash step was added as a means of removing these contaminating proteins. This
modification worked quite well, as evidenced by the near complete disappearance of
contaminating bands in Figure 2-7.B. The few remaining faint bands correspond to
low levels of proteins which could be removed further using size exclusion methods.
Finally, protein obtained using BSA-Sepharose appeared to be nearly perfectly ho-
mogeneous, as seen in Figure 2-7.C,. suggesting the only protein interactions which
occurred using this material were those between the mAb and the BSA ligand. This
result is consistent with Pharmacia's claim that the Sepharose matrix displays negli-
gible non-specific adsorption of proteins. The mAb purified using this material were
therefore judged to be of sufficient homogeneity for use in subsequent experiments.
A comment regarding the observed electrophoretic mobilities of these mAb de-
serves mention. For each mAb the major band showed a relative mobility slightly
less than that for catalase, thus implying a corresponding molecular weight slightly
greater than 230 kDa. This is inconsistent with the expected molecular weight of
IgG (approximately 153 kDa), and would seem to suggest that these bands repre-
sented mAb which had formed dimers or perhaps even larger oligimers. The diversity
in amino acid sequence among different mAb, however, results in corresponding dif-
ferences in electric charge, and thus in their electrophoretic behavior (as seen in
Figure 2-7, where bands corresponding to different mAb appear in slightly different
locations on the gel). In addition, the non-globular nature of IgG may result in
anomalous migration through the porous gel. A measurement of the size of one mAb
(1N16) using an independent light scattering technique (QLS) suggested that its size
corresponded to that of monomeric IgG. We concluded, therefore, that the major
bands observed in the Native PAGE gels represented monomeric mAb, rather than
oligimers of higher molecular weight.
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Thuls, either of the two methods studied (use of BSA-Sepharose or BSA-Acti-
Disk) appeared to be satisfactory for the purification of anti-BSA rnAb from mouse
ascites fluid, provided that an extra wash step is included when using the membrane
cartridge. While it is a slightly quicker and somewhat less cumbersome technique,
use of the BSA-Acti-Disk resulted in slightly lower product purity, thus requiring an
additional chromatography step to obtain pure monomeric mAb.
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Chapter 3
Immunologic and Physicochemical
Characterization of
Antigen-Monoclonal Antibody
Complexes
3.1 Introduction
When a mixture of a single, non-crossreactive mAb and its univalent Ag are prepared,
complexes containing the mAb and either one or two Ag molecules are formed. As-
suming there are no cooperativity effects involved, this equilibrium binding between
mAb and Ag can be characterized by a single intrinsic association (or affinity) con-
stant, Ka:
mAb + Ag N- mAb Ag
mAb. Ag + Ag Ag mAb. Ag
A number of techniques for experimentally determining affinity constants between
mAb and their Ag have been published, among them equlibrium dialysis [13], solid-
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phase radioimmunoassays [25] or enzyme-linked immunosorbent assays [19], and el-
lipsometry measurements [33]. Equilibrium dialysis is generally not well suited for
studying mAb which bind to large proteins, and several of the other techniques in-
volve immobilizing either Ag or mAb to a solid surface, yielding results which may not
represent association in solution. For our investigation we chose a radioimmunoassay
technique developed and used previously in our laboratory [28, 29]. The technique
'was based on precipitation of mAb which had first been allowed to associate with
soluble, radiolabelled Ag. The constant thus obtained should be more representative
of the affinity constant in solution.
When mixtures of Ag and multiple mAb to that Ag are prepared, a distribution
of IC varying in size are formed. This system of Ag, mAb and heterogeneous IC is in
dynamic equilibrium; the equilibria is dependent on the concentrations of all species
present and the intrinsic affinities of the mAb involved. As size is an important
parameter in determining the biological properties of IC in vivo [27], methods to
study the size distributions of IC in solution have been highly sought. Some of these
methods have in the past included gel permeation chromatography [20] and sucrose
density gradient ultracentrifugation [39]. In both of these, significant dilution of the
system occurs, perturbing the equilibria and thus the distribution of IC in solution.
Quasi-elastic laser light scattering (QLS) offers a non-invasive technique for ex-
amining the size distribution of IC in situ. In QLS, a laser beam is focused on the
sample of interest and the light scattered by the proteins in solution is collected at
some angle from the incident beam. The intensity of this scattered light fluctuates in
a time-dependent manner due to the Brownian motion of the molecules in solution;
these fluctuations can in turn be analyzed in order to yield information concerning the
size of the scattering species [3]. Because of the non-invasive nature of this technique,
problems such as dilution are avoided.
In these studies, simple IC were constructed by mixing BSA as the protein Ag
with pairs of anti-BSA mAb. Within each pair studied, each mAb bound to a dif-
ferent, univalent site on the BSA molecule. Under these conditions, only linear and
cyclical IC can be formed. Such a system was previously shown to exhibit many in-
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teresting features characteristic of naturally-occuring IC, and yet was simple enough
for accurate models to be developed [29]
3.2 Materials and Methods
3.2.1 Materials
Monoclonal Antibodies
The mAb used in these experiments were those which were successfully purified in
significant quantities by affinity chromatography, described in Chapter 2. In most
cases, further purification using gel filtration was necessary in order to isolate sam-
ples of antibody which were essentially free of oligimers and other trace contami-
nants. Gel filtration was performed using a Superose 6 HR 10/30 column connected
to a Fast Protein Liquid Chromatography (FPLC) system (Pharmacia Biotech) with
PBSA as the running buffer. Fractions corresponding to monomeric antibody were
collected and concentrated using Amicon Centricon-30 centrifugal concentrators on
a Clay-Adams Sero-Fuge (Becton Dickinson, Parsippany, NJ). Concentrations were
determined by measuring optical density at 280 nm and assuming an extinction co-
efficient for IgG of 1.4 ml/(mg-cm). Antibodies were stored at 4°C in stock solutions
ranging in concentration between 1 and 2 mg/ml.
Bovine Serum Albumin
BSA, monomer standard powder, was obtained from ICN Biomedicals (Costa Mesa,
CA), and was dissolved in PBSA to approximately 2 mg/ml. Further purification
was necessary to isolate monomeric BSA free of oligimers. As with the monoclonal
antibodies, gel filtration was performed using a Superose 6 HR 10/30 column con-
nected to a Pharmacia FPLC system. Fractions which corresponded to monomeric
BSA were collected and concentrated using Amicon Centricon-10 concentrators on a
Clay-Adams Serofuge. Concentrations were determined by measuring optical density
at 280 nm and assuming an extinction coefficient for BSA of 0.66 ml/(mg-cm). Stock
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solutions of monomeric BSA in PBSA (between 1 and 3 mg/ml) were stored at 40C.
3.2.2 Methods
Radiolabelled BSA Binding Experiments
BSA was labelled with I125 by the use of IODOBEAD reagent (Pierce Chemical,
Rockford, IL). The BSA used for labelling was prepared as described above and
diluted in PBSA on the day of labelling (300 g into 500 ul in 3 ml polyethylene tubes).
To this was added 500 pCi of NaI125 (NEN Research Products, Boston, MA), followed
by two pre-rinsed IODOBEADs. The iodination reaction was allowed to proceed
for 15 minutes, and was stopped by removing the mixture from the polyethelene
tube. The beads were quickly washed twice with one ml of PBSA to maximize
protein recovery, and the washes were added to the removed BSA. The recovered
protein was then loaded onto a small BioRad 10DG desalting column in order to
remove non-incorporated label from the protein. Fractions which contained labelled
protein were collected and concentrated using Centricon-10 microconcentrators on a
Clay-Adams Serofuge. Activity measurements (in counts per minute, or CPM) were
made using an Auto-Gamma 500 gamma-counter (Packard Instrument Co., Downer's
Grove, IL). To ensure that most of the activity present corresponded to labelled
protein, 10% trichloroacetic acid was added to precipitate BSA-I'2 5 , and the activity
of precipitate and supernatant were measured. Specific activities of the labelled BSA
were determined prior to each binding experiment by counting 100 1l aliquots of
solutions of known BSA-1125 concentration.
The method used for the determination of binding constants was modified slightly
from one published previously [29]. For each experimental assay, an appropriate
volume of diluent was first added to 250 pl polyethylene microcentrifuge tubes. The
diluent used (referred to as PBSA-TT) was PBSA which contained 0.5 mg/ml porcine
thyroglobulin (Sigma Chemical Co.) to prevent non-specific binding, and 0.05% (v/v)
Tween 20 (Sigma Chemical Co.) to prevent adsorption to surfaces. To each tube was
added the mAb being studied at a total concentration of 2x10-8 M, followed by an
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amount of radiolabelled BSA varying between 3x10- 9 and 3x10-7 M. Volumes of
each reactant were chosen such that the total volume (diluent plus mAb and BSA-
I125) was 150 ill. In order to precipitate all the antibody in each tube, 50 Al of a
slurry (25% (v/v) in PBSA-TT) of agarose beads to which anti-mouse IgG had been
coupled (Sigma Chemical Co.) was added. The tubes were quickly mixed using a
vortex mixer, and were rotated end-over-end at room temperature for two to three
hours to reach equilibrium. The tubes were then centrifuged for five minutes in a
Microfuge B (Beckman Instruments) and 100 pA of supernatant was removed and
transferred to a second microcentrifuge tube. The activity in both precipitate and
supernatant tubes was counted, and concentrations of BSA both bound to antibody
and free in solution were determined as follows:
CP precipitate - CPsupernatant
[BSA]bound supernatant (3.1)Vtotal(SA)
CP[BSA lsupernatant
BSA/jree Vsupernatant(SA) (3.2)
where CPlprecipitate and CPAlsupernatant are the measured counts per minute of the
precipitate and supernatant tubes, respectively; I'total and Vsupernatant are 200 and 100
p1, respectively; and (SA) is the measured specific activity of the labelled BSA in
CPM/mole. Triplicate assays were performed at each BSA-I'25 concentration.
The assay was developed such that all the antibody present will be precipitated
by addition of anti-IgG beads. Under these conditions, the association constant, Ka,
can be determined by the familiar Scatchard equation:
[BS Ab ound bKa [mAb]total - [BSA,d ] bond (33)[BSA]ree
where b corresponds to the valence of the antibody (in this case, b = 2). Plotting the
ratio of bound to free concentrations of BSA versus the bound concentration should
result in a straight line whose negative slope corresponds to the association constant.
34
Quasi-Elastic Laser Light Scattering
Experimental. All measurements were taken using a Brookhaven Instruments (Holts-
ville, NY) light scattering system consisting of a Lexel Model 95 argon ion laser, a
Thorn EMI model B2FBK/RF1 electron tube, and a Brookhaven BI-9000AT auto-
correlator. The laser was operated in the power-control mode at a maximum power
of 300 mW and a wavelength of 514 nm. Scattered light was detected by the electron
tube at an angle of 90° from the incident beam. The sample chamber was maintained
at a temperature of 20.0±0.2°C by means of a Neslab RTE-1000 water bath (Neslab,
Portsmouth, NH). The autocorrelator delay times were adjusted such that the auto-
correlation function displayed a smooth exponential decay, and the total time for a
single measurment was generally set at 120 seconds.
Two types of sample cells were used: the BI-SVC (Small Volume Cell. Brookhaven
Instruments) and 10x75 mm borosilicate glass culture tubes (VWR. Scientific, San
Francisco, CA). The BI-SVC consisted of a brass holder, a white cone-shaped teflon
sleeve, and the actual sample cell. The sample cell consisted of two pieces: a 10
mm OD, 8 mm ID borosilicate glass cell of height 70 mm, and a black teflon insert
machined to fit snugly into the glass cell. The black teflon insert had a small hole
bored along the centerline of the insert, from the top down to a point approximately
8 mm from the bottom. Here a 1.5 mm wide slit was notched into the side, allowing
a very small volume within the insert to be illuminated by the laser (see Figure 3-1).
Measurements were taken on samples which had first been filtered twice through
Millipore HV 0.45 Mum syringe tip filters in order to remove dust and any large aggre-
gates. When using the BI-SVC, the black teflon insert was lowered into the glass cell,
and approximately 50 l of sample was injected via syringe into the hole bored within
the insert, taking care not to overfill the volume formed by the notch. The glass cell
was then covered, inserted into the white teflon sleeve, and the sleeve was placed in
the brass holder positioned in the QLS sample chamber. The position of the cell in
the sleeve was raised or lowered so that the laser beam passed directly through the
notch in the insert. When using 10x75 mm glass culture tubes, approximately 300
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Figure 3-1: BI-S\V'C Sample Cell Schematic.
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uzl of filtered sample was injected into the tube, and the covered tube was positioned
in the teflon sleeve/brass holder such that the laser beam passed through the sample
below the meniscus.
Data Analysis. The time-dependent fluctuations in scattered light intensity detected
by the electron tube can be represented by the second-order intensity autocorrelation
function:
G(2 )() = (I(t)I(t + T)) = lim - I(t)I(t + r)dt (3.4)T-*oo T Jo
where G(2)(r) denotes the time-averaged intensity, I, of the scattered light as a func-
tion of delay time, r (the intensity will in general have different values at times t and
t + T), and T represents the total duration of the experiment. This equation is writ-
ten in terms of a continuous analog signal; in practice, the function is approximated
by taking measurements over discrete intervals. The intensity is estimated by the
number of photons ni counted by the electron tube during a sampling interval AT.
In these terms Equation 3.4 is written as
N
G(2)(r) = (n(t)n(t + )) = lim nini+j (3.5)
N-+o
In this discrete version of Equation 3.4, r = jTr, j takes on integer values from 1 to
m where m is the number of channels in the autocorrelator, t = iAr, and N is the
total number of samples.
Division of Equation 3.5 by its baseline value (G(2)(oo)) gives the normalized
second-order autocorrelation function
9(2 G(2)(r) (n(t)n(t + T)) (3.6))(oo) (n)(3.6)
where G(2)(oo) equals the square of the average photon counting rate, (n)2.
For a dilute solution of independently scattering molecules, the normalized second-
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order autocorrelation function can be written as follows:
9(2)(r) = 1 + MgIg(')(T)12 (3.7)
In Equation 3.7 is an experimental variable related to the optical efficiency of the
system, and gl(T) is the normalized first-order electric field autocorrelation function.
.For a monodisperse solution of rigid, sherical, optically isotropic particles, gl(7) can
be described by the following exponential decay:
Ig(1) () = exp(-FT) (3.8)
Here, F is the inverse time constant for the decay, and is described by
F = q2D (3.9)
as q -+ 0. In Equation 3.9, D is the translational diffusion coefficient. and q is the
magnitude of the scattering vector:
4rnq = -- sin(/2) (3.10)
where n is the refractive index of the solvent, A0 is the wavelength of laser light in
vacuo, and 0 is the angle at which the scattered light is detected. In our studies, n
was assumed to be equal to 1.33, A0 was equal to 514 nm, and 0 was equal to 90°;
therefore, q = 0.023 nm - 1.
Equation 3.8 assumes a solution of monodisperse scatterers. For polydisperse
systems. such as ours, Equation 3.8 must be rewritten:
IAf
ig(1 (T-)l = E Gmexp(-,m) (3.11)
m=1
where now r, = q2Dm, Dm denoting the diffusion coefficient of the mth species,
and Gn the normalized weighting factor which is proportional to the intensity of
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light scattered by the mth species. Assuming a continuous distribution of scatterers,
Equation 3.11 can be converted to integral form:
g(l)()l - 0 G(r)exp(-rr)dr (312)
with
G(r)dr = E G 1 (3.13)
m=1
where G(r) is in effect the distribution of diffusion coefficients, D.
Information regarding G(r) can obtained by the method of cumulants [24], which
is based on exact correspondence between the form of Equation 3.12 and the moment
generating function:
Inlg(l)(r()l - ) k(r) (3.14)
The cumulants k can be expressed in terms of the moments of the distribution; the
experimental data are fit to the following equation:
122r2 P373
nl/l/2g(l)(r)l = ltn/1/ 2 - rZT + 2 (3.15)2 6
Only F, and P2 can be determined with reasonable precision by this method [24].
It can be shown [4] that r, = q2 D,, where D~, the z-averaged diffusion coefficient,
is defined by
D= E CmMtPrmDm (3.16)
, CM Pm
D, can then be used in combination with the Stokes-Einstein equation to determine
a z-averaged hydrodynamic radius:
kT
= ( (3.17)
67r7(Rh)z
where k is Boltzmann's constant, T is the absolute temperature, and 7r is the viscosity
of the solvent. Thus, a measure of the z-averaged size (in terms of a hydrodynamic
radius) of the sample can be determined by this method of analysis.
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Information regarding G(r) can also be obtained by a data-fitting method known
as constrained regularization [34]. Using this technique, an entire distribution of
G(r), as opposed to merely an average of the distribtion, can be determined from the
experimental data, 1g(1)(Tr). This is done by recognizing Equation 3.17 as having the
form of a Fredholin integral of the first kind:
b NL
y(t)= F(A, t)s(A)dA+ Lii + 6 (3.18)
where y(t) represent the noisy experimental data with experimental error , F(A, t)
is some known function, and s(A) is the unknown function which is desired (G(F) in
this case). In the general case, Li and /i account for any constant terms present in
the experiment in our case, we attribute the pi term to dust and set both !/L and Li
equal to one.
The problem of determining the function s(A) is in general an ill-posed one, as
there may be many different solutions which are equally acceptable within the ex-
perimental error. The computer program CONTIN [35] solves this problem by first
converting Equation 3.18 into a system of linear equations:
Ng NL
y(t) = > cmF(Am, t)s(Am) + E Li3i + E (3.19)
m=l i=1
where cm are the weights of Simpson's formula and Ng are the grid points at which
the solution is determined. Equation 3.19 can be rewritten in the following form:
Nx
y(t) = E Atjxj + E (3.20)j=l
where N. = N + N'L, A is the matrix containing c,nF(Am, t), and x is a vector
containing the unknowns s(Am) and /,. CONTIN then solves the system of equations
under two constraints: s(Am) must be non-negative, and parsimony or smoothness is
imposed. This second constraint is met by adding a regularizing term to the normal
least-squares minimization problem:
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V(a) = M-/2(y - Ax)12 + o2 [d A) ]dA = minimum (3.21)
Here, M, is the covariance matrix of errors, , y is the vector containing the data
points y(t), and is a regularization parameter chosen by CONTIN such that the
increase in Vi(a) over V(a = 0 will be due to chance alone approximately half of the
timc.
3.3 Results and Discussion
BSA Binding Experiments
Approximately 600 g BSA was labelled with 1125 using Pierce IODOBEAD reagent.
Greater than 97% of the activity was precipitated by addition of 10% TCA. Specific
activities between 1.6x10'5 and 3.1x1016 CPM/mole (a 0.01 - 0.21 Ci//ig BSA) were
measured.
Prior to the actual binding experiments, control experiments without mAb were
performed to determine the amount of BSA-1125 adsorbing non-specifcally to the anti-
IgG-agarose beads. At BSA-I125 concentrations ranging from 3x10-9--3x10-7 M, less
than 1% of the activity was contained in the precipitate, indicating that non-specific
adsorption was negligible.
Radiolabelled BSA binding experiments were performed for each of the four mAb
purified by affinity chromatography. Figures 3-2 through 3-5 contain binding iso-
therms and Scatchard plots obtained for each. The binding isotherms for mAb 3C2,
1N3 and 1N16 show the expected behavior, with the concentration of bound BSA
increasing asymptotically toward a saturation value as the amount of BSA free in
solution increases. The amount of BSA bound to mAb 3C9 also increases as the
concentration of BSA in solution increases, as seen in Figure 3-3; however, the increase
appears nearly linear, with no apparent leveling off in the isotherm. The saturation
of this mAb appears to occur at concentrations of BSA higher than those used in
these experiments.
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Figure 3-2: Binding Isotherm and Scatchard Plot for mAb 3C2. A. Binding Isotherm.
B. Scatchard Plot. In both figures, data represent average ± standard deviation of
triplicate measurements.
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Figure 3-3: Binding Isotherm and Scatchard Plot for mAb 3C9. A. Binding Isotherm.
B. Scatchard Plot. In both figures, data represent average f standard deviation of
triplicate measurements.
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Figure 3-4: Binding Isotherm and Scatchard Plot for mAb 1N3. A. Binding Isotherm.
B. Scatchard Plot. In both figures, data represent average ± .standard deviation of
triplicate measurements.
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Figure 3-5: Binding Isotherm and Scatchard Plot for mAb 1N16. A. Binding
Isotherm. B. Scatchard Plot. In both figures, data represent average ± standard
deviation of triplicate measurements.
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n P
Correlation Coefficient, r
3C2
3C9
1N3
1N16
0.56±0.06
0.13
1.2
0.41±t0.04
-0.99
-0.69
-0.86
-0.99
Table 3.1: mAb Association Constants.
The Scatchard plots contained in Figures 3-2 through 3-5 are plots of the ratio of
bound to free BSA versus bound BSA concentration for each mAb studied. In general,
they exhibit two types of behavior: those for mAb 3C2 and 1N16 show a fairly linear
decrease of this ratio with increasing bound concentration, whereas those for 3C9 and
1N3 show a decrease with significant curvature. This would suggest that mAb 3C2
and 1N16 behave ideally in terms of their association with BSA; that is, they appear
to bind non-cooperatively to a single epitope on the BSA molecule. 3C9 and 1N3,
on the other hand, do not follow this behavior, and appear to bind the second BSA
molecule with different affinity than the first, perhaps due to cross-reactions with
other epitopes within the BSA structure.
Association constants were determined for each mAb from the Scatchard plot
data. The data from each plot were fit by linear regression to Equation 3.3, and
the resulting value for the slope was taken to be the association constant, K,. In
the case of mAb 3C2 and 1N16, the constant can be considered the intrinsic affinity
constant, whereas for 3C9 and 1N3, it must be considered an average constant, due
to the non-linear nature of the Scatchard data. The resulting values for each mAb,
along with the linear correlation coefficients, are listed in Table 3.1. Experimental
errors in the calculation of affinity constants were not determined for 3C9 and 1N3,
due to the poor linear fit for these mAb.
The amount of BSA bound at saturation can be determined for each mAb from
the x-intercept of the Scatchard plots. The corresponding values are: 3C2, 8.1x10-8
Mi[; 3C9, 3.4x10-8 M; 1N3, 3.8x10-8 M; and 1N16, 5.9x10-8 M. We would expect a
uniform value of 4x10-8 M for each of these mAb, since the concentration of mAb used
for each assay was 2x10-8 M and at saturation there should be two molecules of BSA
bound per mAb. The reason for this discrepency is likely due to a systematic error
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in measurement of mAb concentration. Concentrations of three mAb (3C2, 3C9 and
1N16) were determined by optical density measurements using an extremely small
volume (50 l) spectrophotometer cell. It was later found that the optical density
measurement obtained using this cell was highly dependent upon slight adjustments
in the positioning of the cell within the spectrophotometer. Later measurements
(for mAb 1N3) were obtained using a larger cell (500 jul) which did not exhibit this
systematic error. The saturation value obtained with this mAb is very near the
expected value of 4x10- M.
QLS Experiments
IC were constructed in solution by mixing mAb 3C2 and 1N16 with BSA at a
mAbl:mAb 2:BSA molar ratio of 0.5:0.5:1.0, and the average size of the IC which
were formed was measured using QLS and the method of cumulant analysis. To
examine the dependence of this average size on the concentrations of the species in-
volved, the BSA concentration was varied between 2x10-7 and 6x10-6 M. Figure 3-6
shows the results of the size measurements in terms of the average hydrodynamic
radius, (Rh)z.
The plot shows an increase in (Rh)z with increasing BSA concentration for this set
of mAb. An increase of approximately 20% in (Rh), is observed over an approximate
one and a half order of magnitude increase in BSA concentration. This is comparable
to, although slightly less than, results observed with other sets of mAb pairs to
BSA (between 33 and 70% increases in (Rh)z over a nearly two order of magnitude
increase in BSA concentration [44]). In contrast to those previous results, where the
shape of the curve showed continuous growth with increasing BSA concentration,
the data in Figure 3-6 show an apparant asymptotic growth toward some maximum
size.' Certainly, the expectation is for the size to continue to grow as concentrations
are increased, with very large and insoluble aggregates ultimately being formed. The
appearance of this maximum in Figure 3-6 may be due to the limited amount of data,
however, and may not represent the true trend for this system.
CONTIN analysis of IC formed from BSA and three different pairs of mAb (3C2
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Figure 3-6: Effect of BSA Concentration on IC Size. Equivalent hydrodynamic radius
((Rh)) versus BSA concentration for IC constructed using mAb 3C2 and iN16. Data
points represent averages (±standard deviation) of triplicate measurements on a single
sample.
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Figure 3-7: CONTIN Distribution. Fractional intensity versus size for complexes
prepared from BSA and mAb 3C2 and N16.
+ 1N16, 3C2 + 1N3, and 3C9 + 1N16) was also performed to examine the size dis-
tribution of the IC being formed. IC were prepared at a single BSA concentration
of' lx10 - 6 M and a mAbl:mAb 2:BSA molar ratio of 0.5:0.5:1.0. The resulting distri-
butions are presented in Figures 3-7 through 3-9. Each of these figures represents a
single measurement performed on a single sample.
In each case, the distributions fit to the data show the presence of species with
diameters ranging between 6 and 50 nm (60 to 500 A). The means of the three
distributions are 22, 22, and 21 nm for 3C2 + 1N16, 3C2 + 1N3, and 3C9 + 1N16,
respectively. If the diffusion coefficient of an IgG molecule in solution is taken to be
3.9x10-7 cm2 sec- 1 [37], resulting in a Stokes diameter of 10.8 nm, these distributions
would suggest that IC composed of up to four or five minAb are being formed, with
the mean size representing complexes containig two mAb.
A few subtle differences can be seen among the three distributions in Figures 3-
7 through 3-9. The distributions in Figures 3-7 and 3-9 both appear reasonably
symmetric; however, the overall distribution in Figure 3-9 is shifted toward a lower
Stokes diameter than that in Figure 3-7. It is also interesting to note the presence
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of species of approximately 6.5 nm in the distribution for 3C9 + 1N16. A value for
the hydrodynamic radius of BSA measured by QLS has previously been reported
to be 3.6 nm (7.2 nm in diameter) [44]; thus, the presence of this small species in
the distribution for this pair of mAb would suggest that a large fraction of the BSA
remained unbound at this concentration. Finally, in slight contrast to the other two,
the distribution in Figure 3-8 appears non-symmetric, and displays a higher fraction
of smaller species relative to larger species within the distribution.
Although differences in the distributions can be seen, none appears to be excep-
tionally dramatic, suggesting little differences among the IC that are formed by these
three sets of mAb pairs. This may be due to the fact that within each pair, one of the
mAb involved bound to the 3C subdomain of BSA, and the other bound to the 1N
region. Previous work in our laboratory has shown that both the average size of IC
and their propensity to form cycles may be more strongly influenced by the spatial
locations of the antigenic epitopes than by the intrinsic affinities of the mAb involved
[43, 30]. In the case of IC involving mAb 1N3 and 3C9, we might expect larger ag-
gregates to form if indeed these mAb were cross-reactive with other epitopes. Again,
however, the location and nature of such cross-reactive epitopes might preclude such
multivalent binding from occurring. Regardless of these issues, the results of this
study suggest that mixtures of these pairs of mAb and BSA consist of multimeric IC
large enough for use in complement binding and activation experiments [12].
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Chapter 4
Conclusions and
Recommendations for Future
Work
In this thesis, monoclonal antibodies to bovine serum albumin were purified from
mouse ascites fluid by use of two different affinity chromatography media: Sepharose
CL-4B and an Acti-Disk GTA cartridge, both of which containing immobilized BSA as
the affinity ligand. For Sepharose, CDAP activation chemistry was utilized for ligand
attachment; for the Acti-Disk, the ligand was coupled via pre-existing glutaraldehyde
groups according to the manufacturer's protocol. Both methods resulted in reasonable
quantitative attachment of BSA, with a five mililiter column of the Sepharose and
the Acti-Disk cartridge containing 17.5 and 19.4 mg, respectively. The inablility to
achieve the maximum theoretical capacity with both materials was most likely due
to diffusional limitations in the case of Sepharose, and to improper flow distribution
in the case of the Acti-Disk.
These affinity materials were used to successfully purify four out of a panel of
five monoclonal antibodies to BSA in significant quantities. Three slightly different
methods were performed: the Sepharose column was used with application of a low
pH glycine buffer to elute the bound antibody, and the Acti-Disk cartridge was used
both with and without an extra washing step to enhance purity prior to low pH
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elution. The average yields for the four clones purified (3C2, 3C9, 1N3, and 1N16)
were between 2 and 6 mg/ml of loaded ascites fluid, suggesting concentrations in
ascites which are typical for monoclonal antibodies raised in mouse. Attempts to
purify the fifth monoclonal (2-11) were unsuccsessful, suggesting either an extremely
low affinity of this antibody for BSA, or a significantly lower titre of the antibody in
the ascites fluid received.
Native PAGE gels of the protein obtained using each of the three methods showed
a significant difference in product homogeneity among the methods used. The protein
obtained using the Acti-Disk cartridge without the extra washing step appeared to
consist of a large number of proteins of varying molecular weight. This poor separation
was deemed unsatisfactory, and prompted the inclusion of the extra step when using
that device. Addition of the high salt wash resulted in a vast improvement in antibody
purity, and yielded a product which could be used in further experiments with only
minor additional treatment. Finally, the protein obtained using the Sepharose column
displayed the greatest homogeneity of all three, with only a single band corresponding
to monoclonal antibody appearing on the gel.
Association constants were determined for each of the four monoclonals purified
using radioiodinated BSA in a radioimmunoassay. Association constants were deter-
rained from Scatchard plots of the data and followed the trend 1N3 > 3C2 > 1N16
> 3C9. The data conformed well to a linear relationship for clones 3C2 and 1N16;
thus, the affinty constants determined for these antibodies can be regarded as intrinsic
binding constants. The data for clones 3C9 and 1N3 did not exhibit linear behavior,
suggesting possible cooperativity effects and cross-reaction, and can therefore only be
regarded as average binding constants.
Quasi-elastic light scattering performed on mixtures of pairs of antibodies and
BSA demonstrated that complexes of antigen and antibody were being formed in
these mixtures. In the case of one set (3C2 + 1N16), the average hydrodynamic size
of the system increased with increasing concentration of reactants, indicating that
the increased concentration was shifting the equilibrium toward larger and larger
complexes. Size distributions were also obtained for this set and two other sets (3C2
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+ 1N3, and 3C9 + 1N16) by CONTIN fit of the experimental data. The results
indicated that distributions of aggregates composed of between one and four to five
antibodies were being formed at the concentration studied.
Future work in this area could be extended in a number of directions. First, the
primary motivation for the work reported here was to obtain and characterize mono-
clonal antibodies suitable for use in complement binding and activation studies. The
logical extension would be to use these antibodies to construct immune complexes
for that purpose, beginning with an investigation of their binding to the first compo-
nent of the cascade, Clq, and continuing with experiments involving other relevent
complement proteins.
Second, electron microscopy could be utilized in order to visualize the complexes
which are formed, both in the presence and absence of complement proteins. Micro-
graphs obtained could be used to verify results from light scattering, and in the case
where complement proteins are included, could be analyzed to gain new insight into
the complex-complement association and the effects of this association on complex
size.
Third, complexes formed with these antibodies could be used to further study the
equilibrium and kinetics of their association with a number of Fc-binding proteins,
most notably the immunoadsorbent molecule Staphylococcal protein A. The inclusion
of complement components in these experiments would allow a quantitative measure
of the competition between all these proteins for closely-situated binding sites on the
antibody molecule.
Finally, future research could focus on increasing the complexity of the system
by studying complexes formed from three and possibly more monoclonal antibod-
ies. Such a system should more accurately represent the in vivo case of polyclonal
antibody, but would require additional antibodies (associating with a different BSA
subdomain) than those characterized in this thesis.
54
Bibliography
[1] R. W. Baldwin and R. A. Robbins. Circulating immune complexes in cancer.
In S. Sell, editor, Cancer Markers: Diagnostic and Developmental Significance,
chapter 19, pages 507-531. Humana Press, Clifton, New Jersey, 1980.
[2] D. C. Benjamin and J. M. Teale. The antigenic structure of bovine serum al-
bumin: Evidence for multiple, different, domain-specific antigenic determinants.
Journal of Biological Chemistry, 253:8087-8092, 1978.
[3] V. A. Bloomfield and T. K. Lim. Quasi-elastic laser light scattering. Methods in
Enzymology, pages 415-495, 1978.
[4] J. C. Brown, P. N. Pusey, and R. Dietz. Photon correlation study of polydisperse
samples of polystyrene in cyclohexane. Journal of Chemical Physics, 62:1136-
1144, 1975.
[5] J. R. Brown. Structural origins of mammalian albumin. Federation Proceedings,
35:2141-2144, 1976.
[6] D. R. Burton and J. M. Woof. Human antibody effector function. In Frank J.
Dixon, editor, Advances in Immunology, number 51, pages 1-84. Academic Press,
Inc., 1992.
[7] D. H. Campbell, E. Luescher, and L. S. Lerman. Immunologic adsorbents. I.
Isolation of antibody by means of a cellulose-protein antigen. Proceedings of the
National Acadamy of Science, 37:575-578, 1951.
55
[8] C. Carini, I. Mezzaroma, G. Scano, R. D'Amelio, P. Matricardi, and F. Aiuti.
Characterization of specific immune complexes in hiv-related disorders. Scan-
danavian Journal of Immunology, 26:21-28, 1987.
[9] S. J. Chester, P. Maimonis, P. A. Meitner, and M. P. Vezeridis. An analysis of
immunocomplexes for the detection of the early stages of colon cancer. Cancer,
65:1338-1344, 1990.
[10] B. J. Davis. Disc electrophoresis II: Methods and application to human serum
proteins. Annals of the New York Acadamy of Science, 121:404-427, 1964.
[11] R. O. Dillman. Monoclonal antibodies for treating cancer. Annals of Internal
Medicine, 111:592-603, 1989.
[12] G. Doekes, L. A. van Es, and M. R. Daha. Binding and activation of the first
complement component by soluble immune complexes: Effect of complex size
and composition. Scandinavian Journal of Immunology, 19:99-110, 1984.
[13] H. N. Eisen. General Immunology. J. B. Lippencott Co., Philadelphia, 1990.
[14] L. R. Espinoza. Assays for circulating immune complexes. In Circulating Immune
Complexes: Their Clinical Significance, chapter 3, pages 63-86. Academic Press,
1983.
[15] P. L. Ey, S. J. Prowse, and C. R. Jenkin. Isolation of pure IgG 1, IgG 2a, and
IgG2b using protein A-sepharose. Biochemistry, 15:429-436, 1978.
[16] J. W. Goding. Monoclonal Antibodies: Principles and Practice, chapter 6, pages
219-240. Academic Press, Inc., second edition, 1986.
[17] R. Gross, M. L. Yarmush, J. W. Kennedy, and L. V. Quintas. Antigenesis: A
cascade-theoretical analysis of the size distributions of antigen-antibody com-
plexes. Discrete Applied Mathematics, 19:177-194, 1988.
[18] A. E. Gurvich and Drizlikh G. I. Use of antibodies on an insoluble support for
specific detection of radioactive antigens. Nature, 5:648-649, 1964.
56
[19] P. J. Hogg, S. C. Johnston, M. R. Bowles, S. M. Pond, and D. J. Winzor.
Evaluation of equilibrium constants for antigen-antibody interactions by solid-
phase immunoassay: The binding of paraquat to its elicited mouse monoclonal
antibody. Molecular Immunology, 24:797-801, 1987.
[20] V. Holmskov-Nielson, J. C. Jensenius, K. Erb, and S. Husby. Immune complex
formation analyzed by high-performance size exclusion chromatography using
either I125 -labelled antigen or enzyme-linked immunosorbent assay for detection.
Immunology, 51:809-814, 1984.
[21] G. K6hler and C. Milstein. Continuous cultures of fused cells secreting antibody
of predefined specificity. Nature, 256:495-497, 1975.
[22] J. Kohn and M. Wilchek. 1-Cyano-4-dimethylamino pyridinium tetrafluorobo-
rate as a cyanalating agent for the covalent attachment of ligand to polysaccha-
ride resins. FEBS Letters, 154:209-211, 1983.
[23] J. Kohn and M. Wilchek. The use of cyanogen bromide and other novel cyanalat-
ing agents for the activation of polysaccharide resins. Applied Biochemistry and
Biotechnology, 9:285-305, 1984.
[24] D. E. Koppel. Analysis of macromolecular polydispersity in intensity correlation
spectroscopy: The method of cumulants. Journal of Chemical Physics, 57:4814-
4820, 1972.
[25] A. Larsson, R. Ghosh, and S. Hammarstr6m. Determination of intrinsic affinity
constants of monoclonal antibodies against carcinoembryonic antigen. Molecular
Immunology, 24:569-576, 1987.
[26] 'W. G. Laver and G. M. Air, editors. Immune Recognition of Protein Antigens.
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1985.
[27] M. Mannik. Physicochemical and functional relationships of immune complexes.
Journal of Investigative Dermatology, 74:333-338, 1980.
57
[28] G. A. Morel, D. M. Yarmush, C. K. Colton, D. C. Benjamin, and M. L. Yarmush.
Monoclonal antibodies to bovine serum albumin: Affinity and specificity deter-
minations. Molecular Immunology, 425:7-15, 1988.
[29] R. M. Murphy, R. A. Chamberlin, P. Schurtenberger, C. K. Colton, and M. L.
Yarmush. Size and structure of antigen-antibody complexes: Thermodynamic
parameters. Biochemistry, 29:10889-10899, 1990.
[30] R. M. Murphy, H. Slayter, P. Schurtenberger, R. A. Chamberlin, C. K. Colton,
and M. L. Yarmush. Size and structure of antigen-antibody complexes: Electron
microscopy and light scattering studies. Biophysical Journal, 54:45-56, 1988.
[31] R. M. Murphy, M. L. Yarmush, and C. K. Colton. Determining molecular
weight distributions of antigen-antibody complexes by quasi-elastic light scat-
tering. Biopolymers, 31:1289-1295, 1991.
[32] H. L. Niman and J. H. Elder. mAbs as probes of protein structure: Molecular
diversity among the envelope glycoproteins (gp70s) of the murine retroviruses.
In David H. Katz, editor, Monoclonal Antibodies and T Cell Products, chapter 2,
pages 23-52. CRC Press, Inc., Boca Raton, Florida, 1982.
[33] H. Nygren, M. Kaartinen, and M. Stenberg. Determination by ellipsometry of
the affinity of monoclonal antibodies. Journal of Immunological Methods, 92:219-
225, 1986.
[34] S. W. Provencher. A constrained reqularization method for inverting data rep-
resented by linear algebraic or integral equations. Computational Physics Com-
munications, 27:213-227, 1982.
[35] 'S. W. Provencher. CONTIN: A general purpose constrained regularization pro-
gram for inverting noisy linear algebraic and integral equations. Computational
Physics Communications, 27:229-242, 1982.
58
[36] A. H. Ross, D. Herlyn, and H. Koprowski. Purification of monoclonal antibodies
from ascites using ABx liquid chromatography column. Journal of Immunological
Methods, 102:227-231, 1987.
[37] H. A. Sober, editor. Handbook of Biochemistry. The Chemical Rubber Company,
Cleveland, second edition, 1970.
[38] H. L. Spiegelberg. Biological activities of immunoglobulins of different classes
and subclasses. In Frank J. Dixon, editor, Advances in Immunology, number 19,
pages 259-294. 1974.
[39] J. Steensgard, C. Jacobsen, J. Lowe, N. R. Ling, and R. Jefferis. Theoretical
and ultracentrifugal analysis of immune complex formation between monoclonal
antibodies and human IgG. Immunology, 46:751-760, 1982.
[40] A. K. Szakal, M. H. Kosco, J. P. Smith, and J. G. Tew. Use of monoclonal anti-
bodies in immunocytochemistry and at the light and electron microscopic levels.
In Lawrence B. Schook, editor, Monoclonal Antibody Production Techniques and
Applications, pages 229-264. Marcel Dekker, Inc., 1987.
[41] A. Theofilopoulos and F. J. Dixon. The biology and detection of immune com-
plexes. In F. J. Dixon, editor, Advances in Immunology, number 28, chapter 3,
pages 179-183. Academic Press, Inc., 1979.
[42] J. W. Uhr, K. A. Krolick, and E. S. Vitetta. Selective killing of leukemia cells by
antibody-toxin conjugates. In J. Thomas August, editor, Monoclonal Antibodies
in Drug Development, pages 172-176. American Society for Pharmacology and
Experimental Therapeutics, 1982.
[43] D. M. Yarmush, G. Morel, and M. L. Yarmush. A new technique for mapping
epitope specificities of monoclonal antibodies using quasi-elastic light scattering
spectroscopy. Journal of Biochemical and Biophysical Methods, 14:279-289, 1987.
59
[44] D. M. Yarmush, R. M. Murphy, C. KI. Colton, M. Fisch, and M. L. Yarmush.
Quasi-elastic light scattering of antigen-antibody complexes. Molecular Im-
munology, 25:17-32, 1988.
[45] H. Zola and D. Brooks. Techniques for the production and characterization
of monoclonal hybridoma antibodies. In J. G. R. Hurrell, editor, Monoclonal
Hybridoma Antibodies: Techniques and Applications, chapter 1, pages 4-57. CRC
Press, Inc., Boca Raton, Florida, 1982.
60
